Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of RALBP1 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of RALBP1 mRNA | affects expression | 21346803
|
C480030 |
4-(3-(1-adamantyl)-4-hydroxyphenyl)-3-chlorocinnamic acid |
4-(3-(1-adamantyl)-4-hydroxyphenyl)-3-chlorocinnamic acid results in increased expression of RALBP1 protein | increases expression | 15930313
|
C027576 |
4-hydroxy-2-nonenal |
RALBP1 protein results in decreased susceptibility to 4-hydroxy-2-nonenal | decreases response to substance | 15950949
|
D000255 |
Adenosine Triphosphate |
[[Adenosine Triphosphate co-treated with PRKCA protein] results in increased phosphorylation of RALBP1 protein] which results in increased transport of Doxorubicin | affects cotreatment|increases phosphorylation|increases transport | 16087181
|
D000255 |
Adenosine Triphosphate |
Adenosine Triphosphate promotes the reaction [RALBP1 protein affects the transport of Leukotriene C4] | affects transport|increases reaction | 15386349
|
C088060 |
bisindolylmaleimide |
bisindolylmaleimide results in decreased phosphorylation of RALBP1 protein | decreases phosphorylation | 16087181
|
D003078 |
Colchicine |
Colchicine inhibits the reaction [RALBP1 protein affects the transport of Leukotriene C4] | affects transport|decreases reaction | 15386349
|
D003078 |
Colchicine |
RALBP1 protein affects the transport of Colchicine | affects transport | 15386349
|
D004317 |
Doxorubicin |
[[Adenosine Triphosphate co-treated with PRKCA protein] results in increased phosphorylation of RALBP1 protein] which results in increased transport of Doxorubicin | affects cotreatment|increases phosphorylation|increases transport | 16087181
|
D004317 |
Doxorubicin |
PRKCA protein affects the reaction [RALBP1 protein affects the transport of and affects the susceptibility to Doxorubicin] | affects reaction|affects response to substance|affects transport | 16579994
|
D004317 |
Doxorubicin |
RALBP1 protein affects the export of Doxorubicin | affects export | 15386349
|
D004317 |
Doxorubicin |
RALBP1 protein affects the transport of and affects the susceptibility to Doxorubicin | affects response to substance|affects transport | 16579994
|
D004317 |
Doxorubicin |
RALBP1 protein affects the transport of Doxorubicin | affects transport | 17273774
|
D004317 |
Doxorubicin |
RALBP1 protein modified form affects the susceptibility to Doxorubicin | affects response to substance | 16087181
|
D004317 |
Doxorubicin |
RALBP1 protein results in decreased susceptibility to Doxorubicin | decreases response to substance | 15950949
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of RALBP1 mRNA | decreases expression | 15576828
|
D017997 |
Leukotriene C4 |
Adenosine Triphosphate promotes the reaction [RALBP1 protein affects the transport of Leukotriene C4] | affects transport|increases reaction | 15386349
|
D017997 |
Leukotriene C4 |
Colchicine inhibits the reaction [RALBP1 protein affects the transport of Leukotriene C4] | affects transport|decreases reaction | 15386349
|
D017997 |
Leukotriene C4 |
RALBP1 protein affects the transport of Leukotriene C4 | affects transport | 15386349
|
D012643 |
Selenium |
[Selenium co-treated with Vitamin E] results in decreased expression of RALBP1 mRNA | affects cotreatment|decreases expression | 19244175
|
D012643 |
Selenium |
Selenium results in decreased expression of RALBP1 mRNA | decreases expression | 19244175
|
D014810 |
Vitamin E |
[Selenium co-treated with Vitamin E] results in decreased expression of RALBP1 mRNA | affects cotreatment|decreases expression | 19244175
|
D014810 |
Vitamin E |
Vitamin E results in decreased expression of RALBP1 mRNA | decreases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.12 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.47 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.47 | 14692618 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.67 | 21441931 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
4.16 | 10965797 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.60 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.73 | 15885639 |
MESH:D001528 |
Behcet Syndrome |
|
Colchicine |
6.24 | 15870978 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.87 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.91 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.61 | 19526202 15994142 15136595 18382427 16096432 16322301 18628466 16826403 15939500 16264153 15668708 15993339 18234424 15634643 15692762 17369602 17983394 15567936 16595493 16935488 18695136 17426702 11325840 16115903 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Leukotriene C4 |
5.35 | 12654629 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
4.07 | 16050911 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.98 | 16051944 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.71 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.71 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
4.71 | 16234567 18059187 17876044 16023760 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.20 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.66 | 6189445 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.60 | 17519947 15811867 15476868 16278810 17329180 16952015 16612575 18627295 17131338 15792986 16364871 17924179 16731534 17974986 17308081 17007740 16651473 17382496 16455267 17928571 16242529 16269455 15505089 16109756 17351982 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.98 | 17334414 16243910 |
MESH:D002386 |
Cataract |
|
Adenosine Triphosphate |
4.67 | 15003327 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
2.84 | 6135515 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.95 | 17110522 16105132 15861022 17333356 11677210 16919318 17681005 |
MESH:D003092 |
Colitis |
|
Selenium |
3.92 | 17936198 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18259882 18802399 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
1.92 | 19769572 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.36 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.36 | 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
9.27 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
9.27 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
9.27 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
9.27 | 15131321 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.75 | 18602426 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.88 | 9068938 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.31 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.52 | 17359293 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.33 | 18037988 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
2.92 | 15345470 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.74 | 19069698 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.42 | 17150277 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.60 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
3.04 | 16080930 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.56 | 18006777 16330681 16144979 16879835 12587719 17888722 16244371 16707910 16495754 14766674 18674790 16244372 17875725 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
7.46 | 17481944 |
MESH:D006333 |
Heart Failure |
|
Selenium |
7.46 | 17162251 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.01 | 15692506 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.73 | 16490937 16863852 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.50 | 15147373 18501091 17606976 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
4.15 | 14716179 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.95 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.58 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.56 | 17937319 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
11.55 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
11.55 | 16624496 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.48 | 15369732 16775033 15699352 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
6.48 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
10.35 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
10.35 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
7.67 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.67 | 16705839 |
MESH:D007859 |
Learning Disorders |
|
Colchicine |
5.64 | 11749816 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.33 | 16085563 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.70 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
2.70 | 16169303 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
2.19 | 7678174 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.29 | 2876786 2876784 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
6.29 | 17085340 16842330 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.25 | 16863852 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.67 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
2.67 | 11062179 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.54 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.88 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.70 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
6.42 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
6.42 | 15318939 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.30 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.42 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
6.42 | 15107826 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.61 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.94 | 17415656 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
2.99 | 15857846 19429709 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.87 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
10.87 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
2.99 | 18259882 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.91 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.10 | 16889571 15640375 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.31 | 15555623 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.23 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.23 | 16049721 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.20 | 15930896 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.80 | 11578682 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
5.68 | 11550810 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.33 | 17983394 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.06 | 15087411 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.33 | 17638057 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 17013881 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.38 | 15897917 16868541 15749863 18437689 16888761 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
3.38 | 15084515 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.47 | 16919318 15861022 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.36 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
Leukotriene C4 |
4.78 | 12967936 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.09 | 15675481 15625365 18313854 16767912 17203757 17710206 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.37 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.94 | 17846226 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.11 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.11 | 18551238 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.46 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
3.00 | 15692506 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.70 | 17203757 16767912 15625365 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.12 | 16709447 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.61 | 16517955 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.74 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.25 | 15669648 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.45 | 17909728 16010429 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
8.58 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.58 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
8.58 | 17653716 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.51 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.51 | 10091137 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.42 | 14692618 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.65 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.36 | 17638931 16364871 17678736 17334414 |